1Centrum lekárskej genetiky FN, Bratislava.
Peroxisomes are small structures inside cells that help break down substances, especially long-chain fatty acids. When these structures don't work properly due to genetic mutations, it can lead to serious health problems. These disorders are rare but often severe, affecting the brain, liver, and kidneys. Some cases are generalized, meaning many peroxisomes are affected, while others involve only one enzyme. The most common condition is X-linked adrenoleukodystrophy, which can appear in infants or adults. Diagnosing these disorders requires a combination of biochemical tests, genetic analysis, and imaging. Early detection is important for managing symptoms and improving outcomes.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Peroxisomes perform essential metabolic functions, including the breakdown of various substances under oxygen. These organelles are involved in both alpha and beta-oxidation of carboxylic acids, especially long-chain fatty acids. Hydrogen peroxide, a byproduct of these reactions, is either broken down by catalase or used in other peroxidative processes. Despite this well-established role, the full extent of peroxisomal involvement in disease remains unclear. Some peroxisomal disorders are generalized, affecting peroxisome biogenesis, while others involve single enzyme deficiencies. The clinical presentation of these conditions varies widely. Many patients with generalized peroxisomal dysfunction face severe neurological and organ damage. The overall incidence of these disorders in Western Europe is approximately 1 in 10,000. Understanding the genetic and biochemical mechanisms behind these conditions is an ongoing challenge.
Purpose Of The Study:
This article aims to provide an overview of hereditary peroxisomal metabolic disorders. It focuses on the classification and clinical features of these conditions. The goal is to clarify the distinction between generalized and isolated enzyme deficiency disorders. The study also highlights the importance of accurate diagnosis for effective management. It emphasizes the need for a multidisciplinary approach to diagnosis. The article addresses the challenges in identifying and treating these rare conditions. It reviews the current diagnostic tools available for prenatal and postnatal detection. The purpose is to improve understanding and awareness among medical professionals.
Generalized forms often involve central nervous system, liver, and kidney damage.
Approximately twenty hereditary peroxisomal disorders have been described.
X-linked adrenoleukodystrophy is the most common peroxisomal disorder.
Biochemistry, molecular genetics, morphology, and immunocytochemistry are used.
Most patients die within one year; survival beyond three years is rare.
Main Methods:
The authors use a review approach to synthesize existing knowledge on peroxisomal disorders. They analyze the genetic and biochemical mechanisms involved in these conditions. The study draws on findings from molecular genetics and biochemical assays. It incorporates data from clinical case reports and diagnostic studies. The authors compare generalized and isolated enzyme deficiency disorders. They examine the role of peroxisomal enzymes in disease progression. The review includes an analysis of diagnostic techniques such as immunocytochemistry. The study also considers the clinical implications of these findings.
Main Results:
The review identifies approximately twenty hereditary peroxisomal disorders. Generalized forms include Zellweger syndrome and neonatal adrenoleukodystrophy. These conditions are characterized by severe central nervous system and organ damage. Patients with generalized forms often die within one year of diagnosis. X-linked adrenoleukodystrophy is the most common peroxisomal disorder. It has multiple clinical phenotypes, including adrenomyeloneuropathy in adults. Isolated enzyme deficiencies include Refsum disease and acatalasemia. The study highlights the importance of early diagnosis for improved outcomes.
Conclusions:
The authors suggest that peroxisomal disorders are rare but severe conditions. They emphasize the need for a multidisciplinary diagnostic approach. The review indicates that generalized forms have the worst prognosis. The study supports the use of biochemical and molecular genetic methods for diagnosis. It proposes that early detection can improve patient outcomes. The authors note that X-linked adrenoleukodystrophy has variable clinical manifestations. They suggest that understanding the genetic basis is crucial for management. The study concludes that further research is needed to improve diagnostic and therapeutic strategies.
Most are autosomal recessive, except for X-linked adrenoleukodystrophy.